StonvexLoading…
StonvexStonvexStonvexCore line items from CDXS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $15.25M | $70.39M | $31.47M | $22.87M |
Operating Income | $-8.04M | $-41.74M | $-52.30M | $-33.35M |
Net Income | $-8.70M | $-43.97M | $-53.58M | $-33.96M |
EPS (Diluted) | $-0.10 | $-0.50 | $-0.62 | $-0.40 |
Total Assets | $129.37M | $147.80M | $123.96M | $138.25M |
Total Liabilities | $86.14M | $97.27M | $85.42M | $82.61M |
Cash & Equivalents | $36.57M | $50.79M | $25.35M | $26.76M |
Free Cash Flow OCF − CapEx | $-13.33M | $-23.85M | $-43.42M | $-35.53M |
Shares Outstanding | 90.89M | 90.48M | 90.28M | 90.25M |